Pneumatic Nebulizers Market | Rising Number of Occurrences of Respiratory Illnesses Drive the Market

The global Pneumatic Nebulizers market is projected to be driven by various factors such as rising incidences of chronic respiratory disease, an ageing population, and the need for home healthcare equipment. Asthma affects about 18.4 million individuals in the US, as per the estimates of the Centers for Disease Control and Prevention (CDC). The COVID-19 epidemic has had an influence on every industry, including the pneumatic nebulizers sectors. Patients with COPD or asthma who were informed of the possibility of COVID-19 being spread through the air were unwilling to take inhaled medicines, which are thought to be a source  of immunosuppression and viral transmission.

The expanding elderly population, the rising incidences of chronic respiratory  and health diseases, and the burgeoning need for non-invasive medication delivery systems are all significant drivers driving the market forward. Furthermore, as people become older, there are more occurrences of chronic bronchitis, which is likely to propel the global pneumatic nebulizers market forward. Pneumatic nebulizers are quite simple to use and, in compared to other nebulizers, are cost effective. Additionally, they are appropriate for a wide number of patients, resulting in a high rate of adoption. These factors are likely to work in favor of the global pneumatic nebulizers market in the years. In addition to that, medical and technical developments are likely to assist in the growth of the global pneumatic nebulizers market.

Get Brochure of the Report @

The “global pneumatic nebulizers market” research makes an inclusion of main market segments such as product, end use, and regional markets. It also examines the global pneumatic nebulizers market's present competitiveness over the projected period of 2020 to 2030.

Global Pneumatic Nebulizers Market: Key Trends

The market is projected to expand because to the rising number of occurrences of respiratory illnesses and the growing elderly population. As per the Global Burden of Disease Study, chronic pulmonary respiratory illnesses (COPD) affect about 251 Mn people worldwide, with middle- and low-income countries accounting for more than 90% of COPD fatalities. As a result, the pneumatic nebulizer market is projected to develop in tandem with the growing usage of homecare devices by patients.

Because of the increased incidence of respiratory illnesses like asthma and COPD, as well as the growing elderly population, the demand for portable pneumatic nebulizer is projected to develop rapidly. Because of its ease and efficacy, portable nebulizers are becoming more popular. This is likely to have a favorable impact on the global Pneumatic Nebulizers market. Pneumatic nebulizers were utilized to introduce metallic ionic meta callibrant solutions and nanoparticles, as per a research published in Analytica Chimica Acta in 2020. In addition to that, the World Health Organization (WHO) estimates that 339 million people globally suffer from asthma, with more than 80% of them residing in low- as well as middle-income nations. As a result, these variables are likely to have a favorable influence on the growth of the global pneumatic nebulizers market.

Get Table of Content of the Report @

Global Pneumatic Nebulizers Market: Competitive Assessment

  • OMRON Corp. declared the launch of the Automation Center Tokyo (ATC-TOKYO) in Tokyo in January 2020. Customers can make use of this centre to collaborate with the firm to identify solutions for any problems that arise during manufacturing process.

Some of the well-known players in the global pneumatic nebulizers market are listed below:

  • Allied Healthcare Products, Inc
  • Koninklijke Philips N.V.
  • GF Health Products, Inc.
  • General Electric Company
  • BD (Becton, Dickinson & Company)
  • Vectura Group Plc

Global Pneumatic Nebulizers Market: Regional Assessment

In 2020, North America accounted for a sizable portion of the market. According to the American Lung Association (ALA), COPD affects about 24 Mn individuals in the US. In addition to that, as the elderly population in the US grows, so does the number of operations performed in the nation, boosting regional market growth even more. The Asia Pacific regional market was led by China, which is likely to account for a very high revenue share.

Get Premium Customized Report @

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.


Rohit Bhisey

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Visit Site:

Back to news